Biologics & Biosimilars

AbbVie, Samsung Bioepis in Deal; Humira Biosimilar U.S. Release in 2023

April 8, 2018 • By Tamara Mathias

The ACR Updates Biosimilar Position Statement

April 4, 2018 • By Keri Losavio

DMARDs & Biologics Info for Rheumatology Nurses

March 17, 2018 • By Larry Beresford

The Science Behind Biosimilars

February 27, 2018 • By Arthritis & Rheumatology

Ferumoxytol Injection Receives New Indication, & Application for GP2017 Moves Ahead

February 20, 2018 • By Michele B. Kaufman, PharmD, BCGP

Etanercept Biosimilar Is Effective, Well-Tolerated for Rheumatoid Arthritis

February 16, 2018 • By David Douglas

Health Plans Enact Coverage Policies for Remicade & Infliximab Biosimilars

February 16, 2018 • By From the College

U.S. Appeals Court Invalidates J&J Patent on Remicade

January 24, 2018 • By Reuters Staff

EU Approves Certolizumab Pegol for Pregnant & Nursing Patients

January 23, 2018 • By Michele B. Kaufman, PharmD, BCGP

Should Patients with Rheumatic Disease Switch from Biologic to Biosimilar?

January 19, 2018 • By Susan Bernstein